Targeted Nanoencapsulation of Tunicamycin Reduces Toxicity While Improving its Therapeutic Effectiveness in Pancreatic Cancer CellsDebasmita Dutta(North Dakota State University), Snigdha Banerjee(University of Kansas Medical Center)Research SquareMay 23, 202510.21203/rs.3.rs-6711378/v1Cited by 0SaveCiteExport RISWatch citationsRelated PapersPancreatic Tumor Cell Secreted CCN1/Cyr61 Promotes Endothelial cell migration and Aberrant Neovascularization|Scientific Reports|2014|42A potent betulinic acid analogue ascertains an antagonistic mechanism between autophagy and proteasomal degradation pathway in HT-29 cells|BMC Cancer|2016|37pH-responsive targeted nanoparticles release ERK-inhibitor in the hypoxic zone and sensitize free gemcitabine in mutant K-Ras-addicted pancreatic cancer cells and mouse model|PLoS ONE|2024|14pH-responsive Targeted nanoparticles release ERK-inhibitor in the hypoxic zone Sensitizes Gemcitabine in Mutant K-Ras-addicted Pancreatic Cancer|Research Square|2023|1